Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Monforte

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Antiviral Research|August 11, 2004
2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitorsA Rao, J Balzarini, A Carbone, et al.
Chirality|January 1, 1996
Substituent effects on the enantioselective retention of anti-HIV 5-aryl-delta 2-1,2,4-oxadiazolines on R,R-DACH-DNB chiral stationary phaseC Altomare, S Cellamare, A Carotti, et al.
Antiviral Chemistry & Chemotherapy|September 10, 1999
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitorsA Chimirri, S Grasso, P Monforte, et al.
Antiviral Chemistry & Chemotherapy|September 10, 2003
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitorsA Chimirri, P Monforte, A Rao, et al.
Neuromuscular Disorders : NMD|March 8, 2013
Myotonic dystrophy type 1 and de novo FSHD mutation double trouble: a clinical and muscle MRI studyM Masciullo, E Iannaccone, M L E Bianchi, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
Synthesis, structure and in vitro anti-human immunodeficiency virus activity of novel 3-methyl-1H,3H-thiazolo[3,4-a]benzimidazolesA Chimirri, S Grasso, A M Monforte, et al.
Clinical Neurology and Neurosurgery|June 12, 2010
A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemiaM Luigetti, A Modoni, R Renna, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agentsM L Barreca, A Chimirri, L De Luca, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|September 10, 2014
[Oncofertility program at the Montpellier university hospital 2 years after]M Cayrac, A Rafii, C Vincens, et al.
Biotechnology Progress|July 17, 2018
Review and in silico analysis of fermentation, bioenergy, fiber, and biopolymer genes of biotechnological interest in Agave L. for genetic improvement and biocatalysisM C Tamayo-Ordóñez, B A Ayil-Gutiérrez, Y J Tamayo-Ordóñez, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Antiviral Research|August 11, 2004
2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitorsA Rao, J Balzarini, A Carbone, et al.
Chirality|January 1, 1996
Substituent effects on the enantioselective retention of anti-HIV 5-aryl-delta 2-1,2,4-oxadiazolines on R,R-DACH-DNB chiral stationary phaseC Altomare, S Cellamare, A Carotti, et al.
Antiviral Chemistry & Chemotherapy|September 10, 1999
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitorsA Chimirri, S Grasso, P Monforte, et al.
Antiviral Chemistry & Chemotherapy|September 10, 2003
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitorsA Chimirri, P Monforte, A Rao, et al.
Neuromuscular Disorders : NMD|March 8, 2013
Myotonic dystrophy type 1 and de novo FSHD mutation double trouble: a clinical and muscle MRI studyM Masciullo, E Iannaccone, M L E Bianchi, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
Synthesis, structure and in vitro anti-human immunodeficiency virus activity of novel 3-methyl-1H,3H-thiazolo[3,4-a]benzimidazolesA Chimirri, S Grasso, A M Monforte, et al.
Clinical Neurology and Neurosurgery|June 12, 2010
A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemiaM Luigetti, A Modoni, R Renna, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agentsM L Barreca, A Chimirri, L De Luca, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|September 10, 2014
[Oncofertility program at the Montpellier university hospital 2 years after]M Cayrac, A Rafii, C Vincens, et al.
Biotechnology Progress|July 17, 2018
Review and in silico analysis of fermentation, bioenergy, fiber, and biopolymer genes of biotechnological interest in Agave L. for genetic improvement and biocatalysisM C Tamayo-Ordóñez, B A Ayil-Gutiérrez, Y J Tamayo-Ordóñez, et al.
Pageof 5